Global Spinal Fusion Biologics Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Page: 121
Published Date: 02 Jan 2024
Category: Medical Devices & Consumables
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Spinal Fusion Biologics market size was valued at USD 2203 million in 2023 and is forecast to a readjusted size of USD 3055.7 million by 2030 with a CAGR of 4.8% during review period.
Spinal biologics are an important component of lumbar interbody spine fusion. Biologics are substances that work to alter the local environment by affecting cellular activity, growth, and differentiation through inherent properties of osteogenesis, osteoinduction, and osteoconduction.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
The Global Info Research report includes an overview of the development of the Spinal Fusion Biologics industry chain, the market status of Hospital (Bone Graft, Bone Graft Substitute), Clinic (Bone Graft, Bone Graft Substitute), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Spinal Fusion Biologics.
Regionally, the report analyzes the Spinal Fusion Biologics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Spinal Fusion Biologics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Spinal Fusion Biologics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Spinal Fusion Biologics industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Bone Graft, Bone Graft Substitute).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Spinal Fusion Biologics market.
Regional Analysis: The report involves examining the Spinal Fusion Biologics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Spinal Fusion Biologics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Spinal Fusion Biologics:
Company Analysis: Report covers individual Spinal Fusion Biologics manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Spinal Fusion Biologics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Clinic).
Technology Analysis: Report covers specific technologies relevant to Spinal Fusion Biologics. It assesses the current state, advancements, and potential future developments in Spinal Fusion Biologics areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Spinal Fusion Biologics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Spinal Fusion Biologics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Bone Graft
Bone Graft Substitute
Platelet Rich Plasma (PRP)
Other
Market segment by Application
Hospital
Clinic
Other
Major players covered
Medtronic
J & J
Stryker Corporation
Nuvasive
Zimmer Biomet
Orthofix International
Globus Medical
alphatec spine
K2M
Exactech
Wright Medical Technology
X-Spine
Nutech
Arthrex
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Spinal Fusion Biologics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Spinal Fusion Biologics, with price, sales, revenue and global market share of Spinal Fusion Biologics from 2019 to 2024.
Chapter 3, the Spinal Fusion Biologics competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Spinal Fusion Biologics breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Spinal Fusion Biologics market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Spinal Fusion Biologics.
Chapter 14 and 15, to describe Spinal Fusion Biologics sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Spinal Fusion Biologics
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Spinal Fusion Biologics Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Bone Graft
1.3.3 Bone Graft Substitute
1.3.4 Platelet Rich Plasma (PRP)
1.3.5 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Spinal Fusion Biologics Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Other
1.5 Global Spinal Fusion Biologics Market Size & Forecast
1.5.1 Global Spinal Fusion Biologics Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Spinal Fusion Biologics Sales Quantity (2019-2030)
1.5.3 Global Spinal Fusion Biologics Average Price (2019-2030)
2.1 Medtronic
2.1.1 Medtronic Details
2.1.2 Medtronic Major Business
2.1.3 Medtronic Spinal Fusion Biologics Product and Services
2.1.4 Medtronic Spinal Fusion Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Medtronic Recent Developments/Updates
2.2 J & J
2.2.1 J & J Details
2.2.2 J & J Major Business
2.2.3 J & J Spinal Fusion Biologics Product and Services
2.2.4 J & J Spinal Fusion Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 J & J Recent Developments/Updates
2.3 Stryker Corporation
2.3.1 Stryker Corporation Details
2.3.2 Stryker Corporation Major Business
2.3.3 Stryker Corporation Spinal Fusion Biologics Product and Services
2.3.4 Stryker Corporation Spinal Fusion Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Stryker Corporation Recent Developments/Updates
2.4 Nuvasive
2.4.1 Nuvasive Details
2.4.2 Nuvasive Major Business
2.4.3 Nuvasive Spinal Fusion Biologics Product and Services
2.4.4 Nuvasive Spinal Fusion Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Nuvasive Recent Developments/Updates
2.5 Zimmer Biomet
2.5.1 Zimmer Biomet Details
2.5.2 Zimmer Biomet Major Business
2.5.3 Zimmer Biomet Spinal Fusion Biologics Product and Services
2.5.4 Zimmer Biomet Spinal Fusion Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Zimmer Biomet Recent Developments/Updates
2.6 Orthofix International
2.6.1 Orthofix International Details
2.6.2 Orthofix International Major Business
2.6.3 Orthofix International Spinal Fusion Biologics Product and Services
2.6.4 Orthofix International Spinal Fusion Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Orthofix International Recent Developments/Updates
2.7 Globus Medical
2.7.1 Globus Medical Details
2.7.2 Globus Medical Major Business
2.7.3 Globus Medical Spinal Fusion Biologics Product and Services
2.7.4 Globus Medical Spinal Fusion Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Globus Medical Recent Developments/Updates
2.8 alphatec spine
2.8.1 alphatec spine Details
2.8.2 alphatec spine Major Business
2.8.3 alphatec spine Spinal Fusion Biologics Product and Services
2.8.4 alphatec spine Spinal Fusion Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 alphatec spine Recent Developments/Updates
2.9 K2M
2.9.1 K2M Details
2.9.2 K2M Major Business
2.9.3 K2M Spinal Fusion Biologics Product and Services
2.9.4 K2M Spinal Fusion Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 K2M Recent Developments/Updates
2.10 Exactech
2.10.1 Exactech Details
2.10.2 Exactech Major Business
2.10.3 Exactech Spinal Fusion Biologics Product and Services
2.10.4 Exactech Spinal Fusion Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Exactech Recent Developments/Updates
2.11 Wright Medical Technology
2.11.1 Wright Medical Technology Details
2.11.2 Wright Medical Technology Major Business
2.11.3 Wright Medical Technology Spinal Fusion Biologics Product and Services
2.11.4 Wright Medical Technology Spinal Fusion Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Wright Medical Technology Recent Developments/Updates
2.12 X-Spine
2.12.1 X-Spine Details
2.12.2 X-Spine Major Business
2.12.3 X-Spine Spinal Fusion Biologics Product and Services
2.12.4 X-Spine Spinal Fusion Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 X-Spine Recent Developments/Updates
2.13 Nutech
2.13.1 Nutech Details
2.13.2 Nutech Major Business
2.13.3 Nutech Spinal Fusion Biologics Product and Services
2.13.4 Nutech Spinal Fusion Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Nutech Recent Developments/Updates
2.14 Arthrex
2.14.1 Arthrex Details
2.14.2 Arthrex Major Business
2.14.3 Arthrex Spinal Fusion Biologics Product and Services
2.14.4 Arthrex Spinal Fusion Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Arthrex Recent Developments/Updates
3.1 Global Spinal Fusion Biologics Sales Quantity by Manufacturer (2019-2024)
3.2 Global Spinal Fusion Biologics Revenue by Manufacturer (2019-2024)
3.3 Global Spinal Fusion Biologics Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Spinal Fusion Biologics by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Spinal Fusion Biologics Manufacturer Market Share in 2023
3.4.2 Top 6 Spinal Fusion Biologics Manufacturer Market Share in 2023
3.5 Spinal Fusion Biologics Market: Overall Company Footprint Analysis
3.5.1 Spinal Fusion Biologics Market: Region Footprint
3.5.2 Spinal Fusion Biologics Market: Company Product Type Footprint
3.5.3 Spinal Fusion Biologics Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Spinal Fusion Biologics Market Size by Region
4.1.1 Global Spinal Fusion Biologics Sales Quantity by Region (2019-2030)
4.1.2 Global Spinal Fusion Biologics Consumption Value by Region (2019-2030)
4.1.3 Global Spinal Fusion Biologics Average Price by Region (2019-2030)
4.2 North America Spinal Fusion Biologics Consumption Value (2019-2030)
4.3 Europe Spinal Fusion Biologics Consumption Value (2019-2030)
4.4 Asia-Pacific Spinal Fusion Biologics Consumption Value (2019-2030)
4.5 South America Spinal Fusion Biologics Consumption Value (2019-2030)
4.6 Middle East and Africa Spinal Fusion Biologics Consumption Value (2019-2030)
5.1 Global Spinal Fusion Biologics Sales Quantity by Type (2019-2030)
5.2 Global Spinal Fusion Biologics Consumption Value by Type (2019-2030)
5.3 Global Spinal Fusion Biologics Average Price by Type (2019-2030)
6.1 Global Spinal Fusion Biologics Sales Quantity by Application (2019-2030)
6.2 Global Spinal Fusion Biologics Consumption Value by Application (2019-2030)
6.3 Global Spinal Fusion Biologics Average Price by Application (2019-2030)
7.1 North America Spinal Fusion Biologics Sales Quantity by Type (2019-2030)
7.2 North America Spinal Fusion Biologics Sales Quantity by Application (2019-2030)
7.3 North America Spinal Fusion Biologics Market Size by Country
7.3.1 North America Spinal Fusion Biologics Sales Quantity by Country (2019-2030)
7.3.2 North America Spinal Fusion Biologics Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8.1 Europe Spinal Fusion Biologics Sales Quantity by Type (2019-2030)
8.2 Europe Spinal Fusion Biologics Sales Quantity by Application (2019-2030)
8.3 Europe Spinal Fusion Biologics Market Size by Country
8.3.1 Europe Spinal Fusion Biologics Sales Quantity by Country (2019-2030)
8.3.2 Europe Spinal Fusion Biologics Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9.1 Asia-Pacific Spinal Fusion Biologics Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Spinal Fusion Biologics Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Spinal Fusion Biologics Market Size by Region
9.3.1 Asia-Pacific Spinal Fusion Biologics Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Spinal Fusion Biologics Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10.1 South America Spinal Fusion Biologics Sales Quantity by Type (2019-2030)
10.2 South America Spinal Fusion Biologics Sales Quantity by Application (2019-2030)
10.3 South America Spinal Fusion Biologics Market Size by Country
10.3.1 South America Spinal Fusion Biologics Sales Quantity by Country (2019-2030)
10.3.2 South America Spinal Fusion Biologics Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11.1 Middle East & Africa Spinal Fusion Biologics Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Spinal Fusion Biologics Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Spinal Fusion Biologics Market Size by Country
11.3.1 Middle East & Africa Spinal Fusion Biologics Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Spinal Fusion Biologics Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12.1 Spinal Fusion Biologics Market Drivers
12.2 Spinal Fusion Biologics Market Restraints
12.3 Spinal Fusion Biologics Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13.1 Raw Material of Spinal Fusion Biologics and Key Manufacturers
13.2 Manufacturing Costs Percentage of Spinal Fusion Biologics
13.3 Spinal Fusion Biologics Production Process
13.4 Spinal Fusion Biologics Industrial Chain
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Spinal Fusion Biologics Typical Distributors
14.3 Spinal Fusion Biologics Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Spinal Fusion Biologics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Spinal Fusion Biologics Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Medtronic Basic Information, Manufacturing Base and Competitors
Table 4. Medtronic Major Business
Table 5. Medtronic Spinal Fusion Biologics Product and Services
Table 6. Medtronic Spinal Fusion Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Medtronic Recent Developments/Updates
Table 8. J & J Basic Information, Manufacturing Base and Competitors
Table 9. J & J Major Business
Table 10. J & J Spinal Fusion Biologics Product and Services
Table 11. J & J Spinal Fusion Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. J & J Recent Developments/Updates
Table 13. Stryker Corporation Basic Information, Manufacturing Base and Competitors
Table 14. Stryker Corporation Major Business
Table 15. Stryker Corporation Spinal Fusion Biologics Product and Services
Table 16. Stryker Corporation Spinal Fusion Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Stryker Corporation Recent Developments/Updates
Table 18. Nuvasive Basic Information, Manufacturing Base and Competitors
Table 19. Nuvasive Major Business
Table 20. Nuvasive Spinal Fusion Biologics Product and Services
Table 21. Nuvasive Spinal Fusion Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Nuvasive Recent Developments/Updates
Table 23. Zimmer Biomet Basic Information, Manufacturing Base and Competitors
Table 24. Zimmer Biomet Major Business
Table 25. Zimmer Biomet Spinal Fusion Biologics Product and Services
Table 26. Zimmer Biomet Spinal Fusion Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Zimmer Biomet Recent Developments/Updates
Table 28. Orthofix International Basic Information, Manufacturing Base and Competitors
Table 29. Orthofix International Major Business
Table 30. Orthofix International Spinal Fusion Biologics Product and Services
Table 31. Orthofix International Spinal Fusion Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Orthofix International Recent Developments/Updates
Table 33. Globus Medical Basic Information, Manufacturing Base and Competitors
Table 34. Globus Medical Major Business
Table 35. Globus Medical Spinal Fusion Biologics Product and Services
Table 36. Globus Medical Spinal Fusion Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Globus Medical Recent Developments/Updates
Table 38. alphatec spine Basic Information, Manufacturing Base and Competitors
Table 39. alphatec spine Major Business
Table 40. alphatec spine Spinal Fusion Biologics Product and Services
Table 41. alphatec spine Spinal Fusion Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. alphatec spine Recent Developments/Updates
Table 43. K2M Basic Information, Manufacturing Base and Competitors
Table 44. K2M Major Business
Table 45. K2M Spinal Fusion Biologics Product and Services
Table 46. K2M Spinal Fusion Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. K2M Recent Developments/Updates
Table 48. Exactech Basic Information, Manufacturing Base and Competitors
Table 49. Exactech Major Business
Table 50. Exactech Spinal Fusion Biologics Product and Services
Table 51. Exactech Spinal Fusion Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Exactech Recent Developments/Updates
Table 53. Wright Medical Technology Basic Information, Manufacturing Base and Competitors
Table 54. Wright Medical Technology Major Business
Table 55. Wright Medical Technology Spinal Fusion Biologics Product and Services
Table 56. Wright Medical Technology Spinal Fusion Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Wright Medical Technology Recent Developments/Updates
Table 58. X-Spine Basic Information, Manufacturing Base and Competitors
Table 59. X-Spine Major Business
Table 60. X-Spine Spinal Fusion Biologics Product and Services
Table 61. X-Spine Spinal Fusion Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. X-Spine Recent Developments/Updates
Table 63. Nutech Basic Information, Manufacturing Base and Competitors
Table 64. Nutech Major Business
Table 65. Nutech Spinal Fusion Biologics Product and Services
Table 66. Nutech Spinal Fusion Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. Nutech Recent Developments/Updates
Table 68. Arthrex Basic Information, Manufacturing Base and Competitors
Table 69. Arthrex Major Business
Table 70. Arthrex Spinal Fusion Biologics Product and Services
Table 71. Arthrex Spinal Fusion Biologics Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 72. Arthrex Recent Developments/Updates
Table 73. Global Spinal Fusion Biologics Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 74. Global Spinal Fusion Biologics Revenue by Manufacturer (2019-2024) & (USD Million)
Table 75. Global Spinal Fusion Biologics Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 76. Market Position of Manufacturers in Spinal Fusion Biologics, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 77. Head Office and Spinal Fusion Biologics Production Site of Key Manufacturer
Table 78. Spinal Fusion Biologics Market: Company Product Type Footprint
Table 79. Spinal Fusion Biologics Market: Company Product Application Footprint
Table 80. Spinal Fusion Biologics New Market Entrants and Barriers to Market Entry
Table 81. Spinal Fusion Biologics Mergers, Acquisition, Agreements, and Collaborations
Table 82. Global Spinal Fusion Biologics Sales Quantity by Region (2019-2024) & (K Units)
Table 83. Global Spinal Fusion Biologics Sales Quantity by Region (2025-2030) & (K Units)
Table 84. Global Spinal Fusion Biologics Consumption Value by Region (2019-2024) & (USD Million)
Table 85. Global Spinal Fusion Biologics Consumption Value by Region (2025-2030) & (USD Million)
Table 86. Global Spinal Fusion Biologics Average Price by Region (2019-2024) & (US$/Unit)
Table 87. Global Spinal Fusion Biologics Average Price by Region (2025-2030) & (US$/Unit)
Table 88. Global Spinal Fusion Biologics Sales Quantity by Type (2019-2024) & (K Units)
Table 89. Global Spinal Fusion Biologics Sales Quantity by Type (2025-2030) & (K Units)
Table 90. Global Spinal Fusion Biologics Consumption Value by Type (2019-2024) & (USD Million)
Table 91. Global Spinal Fusion Biologics Consumption Value by Type (2025-2030) & (USD Million)
Table 92. Global Spinal Fusion Biologics Average Price by Type (2019-2024) & (US$/Unit)
Table 93. Global Spinal Fusion Biologics Average Price by Type (2025-2030) & (US$/Unit)
Table 94. Global Spinal Fusion Biologics Sales Quantity by Application (2019-2024) & (K Units)
Table 95. Global Spinal Fusion Biologics Sales Quantity by Application (2025-2030) & (K Units)
Table 96. Global Spinal Fusion Biologics Consumption Value by Application (2019-2024) & (USD Million)
Table 97. Global Spinal Fusion Biologics Consumption Value by Application (2025-2030) & (USD Million)
Table 98. Global Spinal Fusion Biologics Average Price by Application (2019-2024) & (US$/Unit)
Table 99. Global Spinal Fusion Biologics Average Price by Application (2025-2030) & (US$/Unit)
Table 100. North America Spinal Fusion Biologics Sales Quantity by Type (2019-2024) & (K Units)
Table 101. North America Spinal Fusion Biologics Sales Quantity by Type (2025-2030) & (K Units)
Table 102. North America Spinal Fusion Biologics Sales Quantity by Application (2019-2024) & (K Units)
Table 103. North America Spinal Fusion Biologics Sales Quantity by Application (2025-2030) & (K Units)
Table 104. North America Spinal Fusion Biologics Sales Quantity by Country (2019-2024) & (K Units)
Table 105. North America Spinal Fusion Biologics Sales Quantity by Country (2025-2030) & (K Units)
Table 106. North America Spinal Fusion Biologics Consumption Value by Country (2019-2024) & (USD Million)
Table 107. North America Spinal Fusion Biologics Consumption Value by Country (2025-2030) & (USD Million)
Table 108. Europe Spinal Fusion Biologics Sales Quantity by Type (2019-2024) & (K Units)
Table 109. Europe Spinal Fusion Biologics Sales Quantity by Type (2025-2030) & (K Units)
Table 110. Europe Spinal Fusion Biologics Sales Quantity by Application (2019-2024) & (K Units)
Table 111. Europe Spinal Fusion Biologics Sales Quantity by Application (2025-2030) & (K Units)
Table 112. Europe Spinal Fusion Biologics Sales Quantity by Country (2019-2024) & (K Units)
Table 113. Europe Spinal Fusion Biologics Sales Quantity by Country (2025-2030) & (K Units)
Table 114. Europe Spinal Fusion Biologics Consumption Value by Country (2019-2024) & (USD Million)
Table 115. Europe Spinal Fusion Biologics Consumption Value by Country (2025-2030) & (USD Million)
Table 116. Asia-Pacific Spinal Fusion Biologics Sales Quantity by Type (2019-2024) & (K Units)
Table 117. Asia-Pacific Spinal Fusion Biologics Sales Quantity by Type (2025-2030) & (K Units)
Table 118. Asia-Pacific Spinal Fusion Biologics Sales Quantity by Application (2019-2024) & (K Units)
Table 119. Asia-Pacific Spinal Fusion Biologics Sales Quantity by Application (2025-2030) & (K Units)
Table 120. Asia-Pacific Spinal Fusion Biologics Sales Quantity by Region (2019-2024) & (K Units)
Table 121. Asia-Pacific Spinal Fusion Biologics Sales Quantity by Region (2025-2030) & (K Units)
Table 122. Asia-Pacific Spinal Fusion Biologics Consumption Value by Region (2019-2024) & (USD Million)
Table 123. Asia-Pacific Spinal Fusion Biologics Consumption Value by Region (2025-2030) & (USD Million)
Table 124. South America Spinal Fusion Biologics Sales Quantity by Type (2019-2024) & (K Units)
Table 125. South America Spinal Fusion Biologics Sales Quantity by Type (2025-2030) & (K Units)
Table 126. South America Spinal Fusion Biologics Sales Quantity by Application (2019-2024) & (K Units)
Table 127. South America Spinal Fusion Biologics Sales Quantity by Application (2025-2030) & (K Units)
Table 128. South America Spinal Fusion Biologics Sales Quantity by Country (2019-2024) & (K Units)
Table 129. South America Spinal Fusion Biologics Sales Quantity by Country (2025-2030) & (K Units)
Table 130. South America Spinal Fusion Biologics Consumption Value by Country (2019-2024) & (USD Million)
Table 131. South America Spinal Fusion Biologics Consumption Value by Country (2025-2030) & (USD Million)
Table 132. Middle East & Africa Spinal Fusion Biologics Sales Quantity by Type (2019-2024) & (K Units)
Table 133. Middle East & Africa Spinal Fusion Biologics Sales Quantity by Type (2025-2030) & (K Units)
Table 134. Middle East & Africa Spinal Fusion Biologics Sales Quantity by Application (2019-2024) & (K Units)
Table 135. Middle East & Africa Spinal Fusion Biologics Sales Quantity by Application (2025-2030) & (K Units)
Table 136. Middle East & Africa Spinal Fusion Biologics Sales Quantity by Region (2019-2024) & (K Units)
Table 137. Middle East & Africa Spinal Fusion Biologics Sales Quantity by Region (2025-2030) & (K Units)
Table 138. Middle East & Africa Spinal Fusion Biologics Consumption Value by Region (2019-2024) & (USD Million)
Table 139. Middle East & Africa Spinal Fusion Biologics Consumption Value by Region (2025-2030) & (USD Million)
Table 140. Spinal Fusion Biologics Raw Material
Table 141. Key Manufacturers of Spinal Fusion Biologics Raw Materials
Table 142. Spinal Fusion Biologics Typical Distributors
Table 143. Spinal Fusion Biologics Typical Customers
List of Figures
Figure 1. Spinal Fusion Biologics Picture
Figure 2. Global Spinal Fusion Biologics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Spinal Fusion Biologics Consumption Value Market Share by Type in 2023
Figure 4. Bone Graft Examples
Figure 5. Bone Graft Substitute Examples
Figure 6. Platelet Rich Plasma (PRP) Examples
Figure 7. Other Examples
Figure 8. Global Spinal Fusion Biologics Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 9. Global Spinal Fusion Biologics Consumption Value Market Share by Application in 2023
Figure 10. Hospital Examples
Figure 11. Clinic Examples
Figure 12. Other Examples
Figure 13. Global Spinal Fusion Biologics Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global Spinal Fusion Biologics Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Spinal Fusion Biologics Sales Quantity (2019-2030) & (K Units)
Figure 16. Global Spinal Fusion Biologics Average Price (2019-2030) & (US$/Unit)
Figure 17. Global Spinal Fusion Biologics Sales Quantity Market Share by Manufacturer in 2023
Figure 18. Global Spinal Fusion Biologics Consumption Value Market Share by Manufacturer in 2023
Figure 19. Producer Shipments of Spinal Fusion Biologics by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 20. Top 3 Spinal Fusion Biologics Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Top 6 Spinal Fusion Biologics Manufacturer (Consumption Value) Market Share in 2023
Figure 22. Global Spinal Fusion Biologics Sales Quantity Market Share by Region (2019-2030)
Figure 23. Global Spinal Fusion Biologics Consumption Value Market Share by Region (2019-2030)
Figure 24. North America Spinal Fusion Biologics Consumption Value (2019-2030) & (USD Million)
Figure 25. Europe Spinal Fusion Biologics Consumption Value (2019-2030) & (USD Million)
Figure 26. Asia-Pacific Spinal Fusion Biologics Consumption Value (2019-2030) & (USD Million)
Figure 27. South America Spinal Fusion Biologics Consumption Value (2019-2030) & (USD Million)
Figure 28. Middle East & Africa Spinal Fusion Biologics Consumption Value (2019-2030) & (USD Million)
Figure 29. Global Spinal Fusion Biologics Sales Quantity Market Share by Type (2019-2030)
Figure 30. Global Spinal Fusion Biologics Consumption Value Market Share by Type (2019-2030)
Figure 31. Global Spinal Fusion Biologics Average Price by Type (2019-2030) & (US$/Unit)
Figure 32. Global Spinal Fusion Biologics Sales Quantity Market Share by Application (2019-2030)
Figure 33. Global Spinal Fusion Biologics Consumption Value Market Share by Application (2019-2030)
Figure 34. Global Spinal Fusion Biologics Average Price by Application (2019-2030) & (US$/Unit)
Figure 35. North America Spinal Fusion Biologics Sales Quantity Market Share by Type (2019-2030)
Figure 36. North America Spinal Fusion Biologics Sales Quantity Market Share by Application (2019-2030)
Figure 37. North America Spinal Fusion Biologics Sales Quantity Market Share by Country (2019-2030)
Figure 38. North America Spinal Fusion Biologics Consumption Value Market Share by Country (2019-2030)
Figure 39. United States Spinal Fusion Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Canada Spinal Fusion Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Mexico Spinal Fusion Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Europe Spinal Fusion Biologics Sales Quantity Market Share by Type (2019-2030)
Figure 43. Europe Spinal Fusion Biologics Sales Quantity Market Share by Application (2019-2030)
Figure 44. Europe Spinal Fusion Biologics Sales Quantity Market Share by Country (2019-2030)
Figure 45. Europe Spinal Fusion Biologics Consumption Value Market Share by Country (2019-2030)
Figure 46. Germany Spinal Fusion Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. France Spinal Fusion Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. United Kingdom Spinal Fusion Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Russia Spinal Fusion Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Italy Spinal Fusion Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Asia-Pacific Spinal Fusion Biologics Sales Quantity Market Share by Type (2019-2030)
Figure 52. Asia-Pacific Spinal Fusion Biologics Sales Quantity Market Share by Application (2019-2030)
Figure 53. Asia-Pacific Spinal Fusion Biologics Sales Quantity Market Share by Region (2019-2030)
Figure 54. Asia-Pacific Spinal Fusion Biologics Consumption Value Market Share by Region (2019-2030)
Figure 55. China Spinal Fusion Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Japan Spinal Fusion Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Korea Spinal Fusion Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. India Spinal Fusion Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Southeast Asia Spinal Fusion Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Australia Spinal Fusion Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. South America Spinal Fusion Biologics Sales Quantity Market Share by Type (2019-2030)
Figure 62. South America Spinal Fusion Biologics Sales Quantity Market Share by Application (2019-2030)
Figure 63. South America Spinal Fusion Biologics Sales Quantity Market Share by Country (2019-2030)
Figure 64. South America Spinal Fusion Biologics Consumption Value Market Share by Country (2019-2030)
Figure 65. Brazil Spinal Fusion Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Argentina Spinal Fusion Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 67. Middle East & Africa Spinal Fusion Biologics Sales Quantity Market Share by Type (2019-2030)
Figure 68. Middle East & Africa Spinal Fusion Biologics Sales Quantity Market Share by Application (2019-2030)
Figure 69. Middle East & Africa Spinal Fusion Biologics Sales Quantity Market Share by Region (2019-2030)
Figure 70. Middle East & Africa Spinal Fusion Biologics Consumption Value Market Share by Region (2019-2030)
Figure 71. Turkey Spinal Fusion Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Egypt Spinal Fusion Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Saudi Arabia Spinal Fusion Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. South Africa Spinal Fusion Biologics Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. Spinal Fusion Biologics Market Drivers
Figure 76. Spinal Fusion Biologics Market Restraints
Figure 77. Spinal Fusion Biologics Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Spinal Fusion Biologics in 2023
Figure 80. Manufacturing Process Analysis of Spinal Fusion Biologics
Figure 81. Spinal Fusion Biologics Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Medtronic J & J Stryker Corporation Nuvasive Zimmer Biomet Orthofix International Globus Medical alphatec spine K2M Exactech Wright Medical Technology X-Spine Nutech Arthrex
Related Reports
06 Feb 2023
Medical Devices & Consumables
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
